- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-28-0007774

About Centogene India Private Limited
Data last updated:
Centogene India Private Limited is a private limited company based in Delhi, India, a subsidiary of Centogene Ag, Weiherhofstrasse 5, D-79104, Freiburg, Germany. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 24 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2012PTC239252. Its GSTIN is 09AAACQ2881J1Z4 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.04 Lakh. It was formerly known as Qlinics Health Care Private Limited. It is led by directors including Nabendu Das and Francisco De Borja Valor Martinez.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/22 Second Floor Asaf Ali Road, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.64 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹45.45 Lakh (net margin -12.5%) and EBITDA of -₹45.31 Lakh (EBITDA margin -12.5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 5% over five years.
The company has about 29 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Centogene. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹51.3 Lakh; the latest was in August 2013. Its 3 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 1 larger and 2 smaller; the largest is Dindigul Scans Private Limited with revenue of ₹3.69 Cr.
Centogene India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0007774). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website centogene.com.
Company details
Recognitions & Rankings of Centogene India
Contact details
Centogene India Private Limited's registered office is in Delhi, Delhi. Its website is centogene.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1/22 Second Floor Asaf Ali Road, Delhi, India – 110002
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Centogene India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Centogene India operates one associated brand: Centogene. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of biochemical/genetic tests to detect mutations and rare diseases | centogene.com |
Business activity
The main business activity of Centogene India is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Centogene India Private Limited, buy the company report.
Financials of Centogene India Private Limited
FY 2025 filings availableCentogene India Private Limited reported revenue of ₹3.64 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹45.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹45.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.5% | ||||
| Net Profit Margin | -12.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Centogene India Private Limited, buy the company report.
Board of directors of Centogene India Private Limited
Centogene India has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nabendu Das | Director | 01 Apr 2020 | 6 Years 7 Months | Current |
| Francisco De Borja Valor Martinez | Director | 27 Jun 2025 | 1 Years 4 Months | Current |
| Dawood Babu Dudekula | Additional Director | 03 Dec 2025 | 0 Years 11 Months | Current |
Peer comparison
Centogene India Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dindigul Scans Private Limited | ₹3.69 Cr (FY 2025) | 1.0% | Dindigul, Tamil Nadu, India | |||
| Centogene India Private Limitedthis company | ₹3.64 Cr (FY 2025) | -₹45.45 Lakh | -12.5% | 4.0% | 29 | Delhi, India |
| Pro Plus Diagnostic Private Limited | ₹3.63 Cr (FY 2025) | 7.0% | Cuttack, Odisha, India | |||
| Nagercoil Diagnostics Private Limited | ₹3.63 Cr (FY 2025) | -5.0% | Nagercoil, Tamil Nadu, India |
To see the full peer comparison of Centogene India Private Limited, buy the company report.
Auditor
Centogene India Private Limited is audited by Khurana Khurana & Associates LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Khurana Khurana & Associates LLP | FY 2022 | 020532N/C400005 |
Shareholding
The shareholding of Centogene India Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Centogene India Private Limited, buy the company report.
Deals & funding
Centogene India Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹51.3 Lakh; the latest was in August 2013.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2013 | Funding round | ₹26.9 Lakh | Investors: Centogene AG |
| Aug 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2013 | Funding round | ₹24.4 Lakh | Investors: Centogene AG |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Centogene India Private Limited has 1 court case on record: 1 filed by Centogene India. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Court case (Complaint Cases) | Filed by the company against an individual | Pending |
To see the full case history of Centogene India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Centogene India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Centogene India Private Limited has a workforce of 29 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 29 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Centogene India Private Limited, buy the company report.
GST
Centogene India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACQ2881J1Z4 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Centogene India Private Limited, buy the company report.
Recent activity
Centogene India Private Limited has 13 board changes on record since 2019: 4 appointments and 9 cessations. The latest: Dawood Babu Dudekula was appointed as Additional Director on 03 Dec 2025.
4 earlier events are in the company report.
News
Frequently asked questions
Centogene India is an active private limited company based in Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 24 July 2012 (14+ years old) and is registered under CIN U85100DL2012PTC239252.
Centogene India has 3 current directors:
- Nabendu Das - Director
- Francisco De Borja Valor Martinez - Director
- Dawood Babu Dudekula - Additional Director
The latest financial statements of Centogene India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Centogene India is 09AAACQ2881J1Z4, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Centogene India is U85100DL2012PTC239252. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Centogene India has 1 court case on record: 1 filed by the company. 1 is pending.
Centogene India was incorporated on 24 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Centogene India has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹51.3 Lakh; the latest was in August 2013.
The peers of Centogene India by revenue are Dindigul Scans Private Limited, Pro Plus Diagnostic Private Limited, Nagercoil Diagnostics Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Dawood Babu Dudekula was appointed as Additional Director on 03 Dec 2025. Francisco De Borja Valor Martinez ceased to be Additional Director on 29 Sep 2025. Francisco De Borja Valor Martinez was appointed as Director on 27 Jun 2025. Centogene India has 13 board changes on record in total.
Yes, Centogene India is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0007774).

